ERBB2 and endometrial serous adenocarcinoma: In addition, HER2 expression analysis by IHC identified incomplete membranous and basolateral “U-shaped” staining patterns characteristic of the serous component of mixed-type uterine serous carcinomas, which demonstrated the heterogeneity of HER2 signalling in EC subtypes (43, 44).